InvestorsHub Logo
Followers 3
Posts 133
Boards Moderated 0
Alias Born 05/27/2014

Re: None

Thursday, 04/04/2024 3:47:52 PM

Thursday, April 04, 2024 3:47:52 PM

Post# of 26218
Great news today! This sounds like a solid study they’ve put together. If this trial achieves what Halberd has been claiming it’s capable of this is going to be HUGE. Too many possible partnerships to name!

On another note, I remember Hartman releasing a PR back in 2022 or something talking about Extendalife where their extracorporeal therapy can target certain antigens tied directly to the aging process. Remember this? I was thinking maybe Hartman himself has been doing trials with this? He has to be closer to 90 if he went to college in ‘59. Maybe he’s a walking PR for their technology!?